TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ACAD

ACADIA Pharmaceuticals Inc

Healthcare · Biotechnology

20.70$ -6.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

ACADIA Pharmaceuticals Inc (ACAD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,743 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACAD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
617 561 503 456 414 385 351 315 266 540 501 461 766 783 747 760 796 783 755 724 718 700 624 613 602 588 655 643 633 749 855 914 977 1,188 1,132 1,226 1,331 1,564 1,605 1,743
603 548 490 444 402 373 340 301 254 526 476 437 742 760 724 736 730 718 674 646 641 618 542 533 522 508 503 493 499 616 675 729 788 938 871 961 1,076 1,062 1,096 1,225
154 164 157 144 113 69 116 74 64 135 98 74 385 190 173 310 452 326 304 267 95 147 205 140 155 115 291 108 98 189 205 177 155 320 218 254 258 178 282 385
589 529 469 417 367 341 298 257 214 474 414 382 684 697 651 659 644 632 578 557 540 521 446 436 437 417 403 375 346 439 471 501 565 756 682 762 847 820 851 956
5.2 7.1 9.5 12 15 18 23 27 21 28 34 33 32 38 45 46 48 50 57 52 62 65 63 69 56 63 70 84 95 102 100 110 98 105 114 120 139 148 148 166
4.3 4.2 3.9 6.0 5.5 5.2 5.6 4.7 4.3 4.1 4.6 3.8 4.8 6.3 6.3 6.2 8.0 9.7 10 11 14 7.9 7.0 6.3 5.8 6.6 6.1 9.2 21 36 62 72 61 22 23 26 29 35 32 32
3.2 3.1 3.5 3.3 3.0 2.7 2.7 2.8 3.4 3.3 3.7 3.4 13 3.2 5.1 6.7 8.4 9.2 73 71 8.6 66 7.5 64 6.5 62 5.6 – 56 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – 0.0 – – – – – – – – – –
7.4 7.0 6.6 6.3 5.9 5.5 5.2 4.8 4.4 4.1 3.7 3.3 3.0 2.6 2.2 1.8 1.5 1.1 0.7 0.4 – – – – – – 70 68 67 65 110 108 106 120 117 114 112 109 106 103
39 43 45 41 36 49 47 50 43 61 83 72 76 84 109 97 141 156 174 160 151 159 179 178 177 187 281 247 270 317 391 397 400 455 367 403 413 337 357 436
39 43 45 41 36 49 46 49 42 60 75 64 68 75 100 86 92 106 109 95 88 96 120 118 117 126 224 188 210 254 331 338 344 395 303 330 357 277 306 361
– – – – – – – – – – 4.5 4.4 3.9 3.4 2.9 2.7 3.9 5.1 6.1 7.5 8.2 8.3 8.9 9.0 9.2 9.3 9.2 9.1 9.0 9.4 10 10 8.9 10.0 11 12 12 12 12 14
2.8 3.9 2.2 3.6 3.0 8.8 3.0 3.3 3.0 3.2 3.3 4.7 3.4 7.2 6.6 6.5 3.5 8.5 8.8 9.1 7.7 6.9 11 12 10 13 17 19 12 18 19 20 19 16 18 20 22 11 12 45
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 6.8 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
578 518 458 415 377 335 304 265 223 479 418 389 689 699 638 663 655 627 582 565 567 541 445 435 426 400 374 396 362 432 464 517 577 733 765 822 917 1,227 1,248 1,307
-855 -934 -1,022 -1,090 -1,155 -1,224 -1,278 -1,341 -1,403 -1,469 -1,554 -1,609 -1,651 -1,704 -1,792 -1,834 -1,919 -1,986 -2,052 -2,096 -2,110 -2,154 -2,267 -2,301 -2,328 -2,370 -2,413 -2,411 -2,477 -2,431 -2,414 -2,381 -2,348 -2,204 -2,185 -2,159 -2,087 -1,813 -1,810 -1,778
117 121 122 122 122 124 125 125 125 132 144 144 146 154 155 157 158 159 160 160 161 161 161 162 162 162 162 165 164 167 167 166 166 166 168 169 171 171 173 173

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?